Daily BriefsFinancials

Daily Brief Financials: Joy City Property, IP Group PLC, Jafco Co Ltd, Coinbase Global , Molten Ventures , Record PLC and more

In today’s briefing:

  • Joy City (207 HK): 17th November Vote On COFCO’s Offer
  • Joy City Property (207 HK): Wide Spread Ahead of the 17 November Scheme Vote
  • IP Group — Pfizer-Metsera deal offers upside potential
  • Jafco Co Ltd (8595 JP): 1H FY 03/26 flash update
  • Coinbase Is Going All-In on Tokenized Assets—Here’s What The Echo Acquisition Brings to the Table!
  • Molten Ventures — Good momentum unfolding in H126
  • Record — Highest level of reported AUM in Q226


Joy City (207 HK): 17th November Vote On COFCO’s Offer

By David Blennerhassett

  • On the 31sr July, Chinese property play Joy City (207 HK) announced a Scheme buyback, @ $0.62/share (declared final), a 67.57% premium; but arguably a 158% premium to undisturbed.
  • Yes, this was a ~70% discount to NAV. However, Joy City had traded at P/B of 0.14x, on average, the past five years. Earnings have trended south in that timeframe.
  • The Scheme Document’s now out, with a Court Meeting on the 17th November and expected payment around the 4th December. The IFA (Somerley) says “fair & reasonable”. It probably is.

Joy City Property (207 HK): Wide Spread Ahead of the 17 November Scheme Vote

By Arun George

  • Joy City Property (207 HK)’s IFA opines that the share buyback by way of a scheme at HK$0.62 is fair and reasonable. The vote is on 17 November. 
  • While the offer implies a P/B of 0.29x, it is reasonable compared to peer multiples and historical trading ranges. No disinterested shareholder holds a blocking stake.
  • Nevertheless, there remains vote risk and caution is warranted. At the current price and for a 4 December payment, the gross/annualised spread is 8.8%/103.6%. 

IP Group — Pfizer-Metsera deal offers upside potential

By Edison Investment Research

There have been several announcements on technical and commercial progress across IP Group’s portfolio this year. A recent highlight was Pfizer’s announcement that it will acquire Metsera. IP Group has the potential to generate significant income from the intellectual property (IP) related to anti-obesity programmes that it owns and exclusively licenses to Zihipp, which Metsera acquired in 2023. Metsera’s drug candidates represent a multi-billion dollar revenue opportunity, of which IP Group may receive a low-single-digit percentage amount of royalty income, on top of which it may collect technical and commercial milestone payments, as well as an earn-out related to its previous equity investment in Zihipp. Other notable announcements across IP Group’s life sciences portfolio include Istesso’s encouraging data, published in The Journal of Pharmacology and Experimental Therapeutics, and clinical trial progress of other holdings. We also note that three of IP Group’s portfolio companies (Oxford Nanopore Technologies (ONT), Oxford Quantum Circuits and Oxa) were featured in NVIDIA’s press release on building the UK’s AI infrastructure.


Jafco Co Ltd (8595 JP): 1H FY 03/26 flash update

By Shared Research

  • JAFCO’s revenue and profits declined YoY, with revenue at JPY11.9bn and net income at JPY1.9bn.
  • Capital gains were JPY4.4bn, with a 1.84x investment multiple, and one domestic IPO was executed.
  • Total investment in 1H FY03/26 was JPY13.7bn, with JPY7.7bn in domestic VC investments across eight companies.

Coinbase Is Going All-In on Tokenized Assets—Here’s What The Echo Acquisition Brings to the Table!

By Baptista Research

  • Coinbase’s second quarter 2025 performance indicates a mixed bag of financial and strategic outcomes.
  • The company reported a total revenue of $1.5 billion and an adjusted EBITDA of $512 million, showing robust financial health.
  • This result underscores the company’s effective management of its core businesses, despite a 40% decline in total trading volume influenced by macroeconomic conditions, lower volatility, and a strategic emphasis on revenue over trading volume for stablepairs.

Molten Ventures — Good momentum unfolding in H126

By Edison Investment Research

Molten Ventures expects to deliver a solid 7.2% NAV per share total return, according to its H126 trading update, supported by a 5.5% constant currency increase in gross portfolio value (driven by value-creation activities and improving market multiples) and a c 1.9% NAV accretion from buybacks. The company continues to deliver strong realisations with £62m in proceeds in H126, representing 4.5% of opening gross portfolio value (broadly in line with its through-the-cycle target of 10% per year). Management highlighted that its portfolio remains ‘robust and resilient’, with respect to both funding requirements and revenue growth, and that its Core portfolio demonstrates strong growth and profitability metrics. Based on the 719p NAV reported in Molten’s trading update, its last closing share price implies a 34% discount to NAV.


Record — Highest level of reported AUM in Q226

By Edison Investment Research

Record reported steady progress in its Q226 trading update. Assets under management (AUM) grew by 2% in the quarter to $110.3bn, the highest level reported for Record, primarily driven by positive asset movements of $2.3bn. Crystallised Q2 performance fees of £0.5m were slightly below the run-rate end-FY26 estimate of £3m. Importantly, the first deployment of €100m of capital from the Infrastructure Equity fund will add incremental management fees for the group. We are not changing our estimates at this stage, and await the full set of H1 results on 7 November.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars